StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
National Health Partners (HPR) Enters ACTIMMUNE Phase 1 with Fox Chase Cancer Center
December 14, 2015 7:02 AM
Horizon Pharma plc (NASDAQ: HZNP) announced that it, in collaboration with Fox Chase Cancer Center Temple Health, has initiated a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Next Articles
Mizuho Securities Raises Price Target to $36 Following Horizon Pharma's (HZNP) Announced Crealta Deal
December 14, 2015 8:15 AM
Horizon Pharma plc and Fox Chase Cancer Center Temple Health Initiate Phase 1 Study to Evaluate ACTIMMUNE(R) (interferon gamma-1b) in Combination With Nivolumab in Patients With Advanced Solid Tumors
December 14, 2015 7:00 AM